Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?

C. L. Gaston, R. Bhumbra, M. Watanuki, A. T. Abudu, S. R. Carter, L. M. Jeys, R. M. Tillman, R. J. Grimer

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

We retrospectively compared the outcome after the treatment of giant cell tumours of bone either with curettage alone or with adjuvant cementation. Between 1975 and 2008, 330 patients with a giant cell tumour were treated primarily by intralesional curettage, with 84 (25%) receiving adjuvant bone cement in the cavity. The local recurrence rate for curettage alone was 29.7% (73 of 246) compared with 14.3% (12 of 84) for curettage and cementation (p = 0.001). On multivariate analysis both the stage of disease and use of cement were independent significant factors associated with local recurrence. The use of cement was associated with a higher risk of the subsequent need for joint replacement. In patients without local recurrence, 18.1% (13 of 72) of those with cement needed a subsequent joint replacement compared to 2.3% (4 of 173) of those without cement (p = 0.001). In patients who developed local recurrence, 75.0% (9 of 12) of those with previous cementation required a joint replacement, compared with 45.2% (33 of 73) of those without cement (p = 0.044).

Original languageEnglish
Pages (from-to)1665-1669
Number of pages5
JournalJournal of Bone and Joint Surgery - Series B
Volume93 B
Issue number12
DOIs
Publication statusPublished - 2011 Dec

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?'. Together they form a unique fingerprint.

  • Cite this